132 related articles for article (PubMed ID: 7908234)
1. Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.
Mannucci PM; Brettler DB; Aledort LM; Lusher JM; Abildgaard CF; Schwartz RS; Hurst D
Blood; 1994 Apr; 83(7):1958-62. PubMed ID: 7908234
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
Lorenzo JI; Molina R; Aznar JA
Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
[TBL] [Abstract][Full Text] [Related]
3. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Goldsmith JM; Deutsche J; Tang M; Green D
Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
[TBL] [Abstract][Full Text] [Related]
4. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
5. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1.
Teitel JM; Freedman JJ; Garvey MB; Kardish M
Am J Hematol; 1989 Dec; 32(4):262-72. PubMed ID: 2573270
[TBL] [Abstract][Full Text] [Related]
6. [Immunological investigation in hemophiliacs with and without human immunodeficiency virus (HIV) infection].
Pang XG; Tang DJ
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):685-7, 729-30. PubMed ID: 1840032
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
8. Immunologic investigation of Chinese hemophiliacs with and without human immunodeficiency virus infection.
Tang DJ; Pang XG
Chin Med J (Engl); 1991 Oct; 104(10):803-7. PubMed ID: 1752140
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive study of immunological abnormalities in Korean hemophiliacs.
Kim KY; Yang CH; Kang SH; Kim DS
Yonsei Med J; 1989; 30(2):180-5. PubMed ID: 2508331
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.
Lederman MM; Jackson JB; Kroner BL; White GC; Eyster ME; Aledort LM; Hilgartner MW; Kessler CM; Cohen AR; Kiger KP
J Infect Dis; 1995 Jul; 172(1):228-31. PubMed ID: 7797917
[TBL] [Abstract][Full Text] [Related]
11. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B
AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874
[TBL] [Abstract][Full Text] [Related]
13. Decrease of CD4 cell number and function in HIV-seropositive hemophiliacs in a longitudinal study.
Knutsen AP; Bouhasin JD; Joist JH; Scrivner D; Mueller KR; Gioia K; Janney S
Ann Allergy; 1989 Sep; 63(3):189-94. PubMed ID: 2528308
[TBL] [Abstract][Full Text] [Related]
14. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate.
de Biasi R; Rocino A; Miraglia E; Mastrullo L; Quirino AA
Blood; 1991 Oct; 78(8):1919-22. PubMed ID: 1822966
[TBL] [Abstract][Full Text] [Related]
15. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.
Seremetis S; Lusher JM; Abildgaard CF; Kasper CK; Allred R; Hurst D
Haemophilia; 1999 Jan; 5(1):9-16. PubMed ID: 10215942
[TBL] [Abstract][Full Text] [Related]
17. A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII.
Brettler D
Ann Hematol; 1994; 68 Suppl 3():S49-50. PubMed ID: 7910039
[No Abstract] [Full Text] [Related]
18. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
19. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
Cuthbert RJ; Ludlam CA; Steel CM; Beatson D; Peutherer JF
Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
[TBL] [Abstract][Full Text] [Related]
20. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
